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A B S T R A C T   
Human milk oligosaccharides (HMO), the third most abundant component of human milk, are thought to be 
important contributors to infant health. Studies have provided evidence that geography, stage of lactation, and 
Lewis and secretor blood groups are associated with HMO profile. However, little is known about how variation 
across the genome may influence HMO composition among women in various populations. In this study, we 
performed genome-wide association analyses of 395 women from 8 countries to identify genetic regions asso-
ciated with 19 different HMO. Our data support FUT2 as the most significantly associated (P < 4.23− 9 to P <
4.5− 70) gene with seven HMO and provide evidence of balancing selection for FUT2. Although polymorphisms in 
FUT3 were also associated with variation in lacto-N-fucopentaose II and difucosyllacto-N-tetrose, we found little 
evidence of selection on FUT3. To our knowledge, this is the first report of the use of genome-wide association 
analyses on HMO.   
1. Introduction 
Milk is highly complex and contains a variety of constituents 
including carbohydrates, lipids, unconjugated complex carbohydrates 
(human milk oligosaccharides, HMO), proteins, immune factors 
(including immune cells), and non-nutritive biologically-active sub-
stances (e.g., enzymes, hormones) [1]. In human milk, aside from water, 
carbohydrates are the predominant component with lactose 
concentrations ranging from approximately 63–77 g/L and lipids 
comprising approximately 30–45 g/L [2]. HMO are the third most 
abundant milk component with combined totals ranging between 
approximately 5–15 g/L [3]. Although little variation has been reported 
in human milk lactose levels, concentrations of both lipid and HMO 
profiles appear to be associated with a number of factors. For example, 
diet and genetic variation of the fatty acid desaturase genes are thought 
to influence fatty acid composition of human milk [4]. HMO 
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concentrations have been reported to vary across lactation stage, sea-
sonality, and geographical locations [5–8]. The variability in HMO 
concentration has also been partially explained by functional properties 
of enzyme products from two genes: fucosyltransferase 2 (FUT2) and 
fucosyltransferase 3 (FUT3). However, aside from these two genes, little 
is known about other potential genetic drivers of this variation. 
There have been up to 200 different HMO structures characterized 
[9]. Core oligosaccharide structures can be modified with addition of 
moieties such as fucose, N-acetylglucosamine (GlcNAc), and sialic acid 
(N-acetylneuraminic acid, NeuAc). The addition of these components to 
the core structures is regulated by enzymes such as α-1,2-fucosyl-
transferase and α-1-3/4-fucosyltransferase, which notably, are the same 
enzymes involved in determination of blood group characteristics. These 
enzymes are encoded by FUT2 and FUT3, respectively. For instance, 
women who produce milk containing higher concentrations of some 
HMO, including 2′-fucosyllactose (2’FL) and difucosyllactose (DFLac), 
are referred to as “secretors” and thought to have a functional FUT2 gene 
product (α-1,2-fucosyltransferase). Conversely, women who produce 
milk with negligible amounts of these HMO are classified as “non-se-
cretors” and are thought to lack a functional α-1,2-fucosyltransferase 
[10–12]. FUT3, also known as the Lewis gene, regulates the expression 
of Lea and Leb antigens, and women who lack a functional enzyme from 
this gene produce milk with little lacto-N-fucopentaose-2 (LNFP II) [13]. 
Substantial research has been conducted to investigate how HMO can be 
grouped by secretor and/or Lewis phenotypic status; however, a thor-
ough investigation into the relationships between genetic poly-
morphisms across these genes and across the human genome and HMO 
composition has not been attempted. Filling this research gap is 
important because secretor status is not only associated with HMO 
composition but also has been linked to increased susceptibility to dis-
ease [14] and conversely, resistance to disease [15] in some infants. 
Elucidating the genetic components that influence secretor status and 
HMO composition are key to understanding the underlying mechanisms 
that influence the health status of the mother and her infant. 
In the present study, we conducted a genome-wide association study 
(GWAS) to examine how maternal genetic variation is related to HMO 
profiles and concentrations. Furthermore, we analyzed the genetic di-
versity of FUT2 and FUT3 to assess the likelihood that evolutionary se-
lective forces have impacted variation in these genes. 
2. Methods 
2.1. Study populations 
Samples used in these analyses were collected as part of a cross- 
sectional study that has been described previously [8]. Briefly, milk 
(n = 410) and saliva samples (n = 405) were obtained from women 
living in 2 regions of the United States (ethnically heterogeneous resi-
dents of southeastern Washington and northwestern Idaho [USW] and 
self-identified Hispanic residents of southern California [USC]), Peru 
(peri-urban area of Lima [PE]), Sweden (near Helsingborg and self- 
identified as having Nordic heritage [SW]), Spain (recruited in 
Madrid, Zaragoza, Huesca, and Vizcaya with no conditions regarding 
ethnicity [SP]), and 6 sub-Saharan African groups (rural and urban 
Ethiopia [ETR and ETU, respectively], rural and urban Gambia [GBR 
and GBU, respectively], Kenya [KE], and Ghana [GN]). Ethics approvals 
were obtained for all procedures from each participating institution, and 
overarching approval was obtained from the Washington State Univer-
sity Institutional Review Board (13264). After being translated from 
English (when needed), informed written consent or verbal (depending 
on the locale, subject’s literacy level, and when approved by the IRB 
boards) was acquired from each participating woman. 
2.2. Human milk and oligosaccharide analysis 
Milk collection and oligosaccharide analysis have been described 
previously [8,16]. Absolute concentrations were calculated on the basis 
of standard response curves for each of the following HMO: 2′FL, 3-fuco-
syllactose (3FL), 3′-sialyllactose (3′SL), 6′-sialyllactose (6′SL), difuco-
syllactose (DFLac), difucosyllacto-N-hexaose (DFLNH), difucosyllacto- 
N-tetrose (DFLNT), disialyllacto-N-hexaose (DSLNH), disialyllacto-N- 
tetraose (DSLNT), fucodisialyllacto-N-hexaose (FDSLNH), fucosyllacto- 
N-hexaose (FLNH), lacto-N-fucopentaose (LNFP) I, LNFP II, LNFP III, 
lacto-N-hexaose (LNH), lacto-N-neotetraose (LNnT), lacto-N-tetrose 
(LNT), sialyl-lacto-N-tetraose b (LSTb), and sialyl-lacto-N-tetraose c 
(LSTc). “Secretor” milk was defined as having a 2’FL concentration >
200 nmol/mL. HMO data (nmol/mL) were tested for assumptions of 
normality and were transformed as needed by performing a squared 
function. 
2.3. Maternal saliva collection and genotyping 
Saliva was collected from each participant using the DNAgard Saliva 
kit (USA Biomātrica, San Diego, CA). Genomic DNA was extracted from 
1 mL preserved saliva using the Gentra Puregene Blood DNA extraction 
kit (Qiagen, Valencia, CA) following the manufacturer’s instructions and 
genotypes were obtained with Illumina Multi-Ethnic Global-8 v1.0 ar-
rays (MEGA; https://www.illumina.com/products/by-type/microarray 
-kits/infinium-multi-ethnic-global.html) following manufacturer’s rec-
ommended protocol by Neogen Genomics (GeneSeek, Lincoln, NE). The 
MEGA contains >1.7 × 106 single-nucleotide polymorphisms (SNPs) 
spanning all chromosomes of the human genome and includes markers 
that include “highly informative SNP for GWAS analyses in European 
and East Asian descent populations for backwards compatibility with 
other genotyping arrays” [17]. Additionally, the customized content of 
markers was chosen to expand the discovery of associations related to 
metabolic, cardiovascular, renal, inflammatory, anthropometric, and 
other traits across multiple ethnicities and associations to less frequent 
(1–5%) and rare (<1%) genetic variants. Genotypes were called using 
GenomeStudio 2.0 (Illumina Inc., San Diego, CA) and analyzed using 
SNP & Variation Suite software (SVS; version Win64 8.7.2; Golden 
Helix, Bozeman, MT). Quality control approaches excluded markers 
based on the following criteria: call rates <89.5% (10,027 SNPs), minor 
allele frequencies <0.0095 (640,954 SNPs), and Hardy-Weinberg equi-
librium (HWE) of P < 1 × 10− 70 (552 SNPs). Two samples were excluded 
due to call rates <87%. After filtering, data from 395 women and 
1,128,286 SNPs were retained for subsequent analyses. 
2.4. Statistical tests 
Associations between the HMO phenotypes and SNPs were evaluated 
using the efficient mixed-model association eXpedited (EMMAX) 
method [18] as implemented in SVS with an additive genetic model. 
Briefly, this method approximates the variance components, uses the 
same variance for all probes, and adjusts for pair-wise genetic related-
ness among all samples using a kinship matrix. Single-locus models were 
performed initially, followed by multi-locus models for any HMO that 
displayed associations across chromosomes [19,20]. All reported gene 
and SNP locations were reported based on the human genome build, 
GRCh38 (https://www.ncbi.nlm.nih.gov/genome/guide/human/). 
Significance for an association was declared at P < 1 × 10− 8. 
2.5. Haplotype analysis 
Phased haplotypes for FUT2, consisting of 24 markers spanning from 
the 1st intron (rs418821; 19:48696547) to the 3′ untranslated region 
(UTR) (rs503279; 19:48705753) and FUT3, consisting of 8 markers from 
the 1st intron to the UTR of FUT3, were obtained using default param-
eters in PHASE 2.1 [21,22]. Median joining networks [23] were con-
structed using phased genotypes and PopART (http://popart.otago.ac. 
nz) [24]. Haplotypes for FUT2 were considered to be ‘se’ or nonfunc-
tional if the allele at rs601338 coded for a stop codon and ‘Se’ if the allele 
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was functional. 
2.6. Genetic diversity analysis 
Two measures of nucleotide diversity, namely the average number of 
pairwise differences in a given region (π) and Tajima’s D [25], were 
obtained for FUT2 and FUT3 (24 and 8 markers, respectively) using 
PopART and used to compare SNP frequencies in FUT2 and FUT3 gene 
regions. Tajima’s D is a test statistic used to determine if the differences 
in distribution of allele frequencies are greater or less than the expected 
variation under the neutral theory, i.e. from that evolving randomly. 
Significant positive values for Tajima’s D indicate an excess of inter-
mediate frequency variants and suggest balancing selection; while 
negative Tajima’s D indicate a selective sweep and high frequency of 
rare variants. Nucleotide diversity (π) provides a summary statistic that 
is used to detect selection; whereby, low diversity is considered a sign of 
directional selection. 
3. Results 
3.1. Genome-wide association analyses of individual HMO 
A GWAS analysis was performed to identify genomic regions or genes 
associated with various HMO. Of the 19 HMO examined, variation in 
concentrations of 11 were associated with variation in 5 different re-
gions of the human genome. The most significant associations for each 
HMO are provided in Table 1; all significant associations, defined as 
those less than P < 10− 8, are provided in Supplementary Table 1. Seven 
HMO (2’FL, DFLac, LNFP I, LNFP II, FSDLNH, LNT, and LSTb; Supple-
mentary Fig. S1) were associated with many of the same genetic variants 
within the FUT2 gene of chromosome 19. Specifically, rs679574 and 
rs516316 exhibited the strongest association (P < 4.50 × 10− 70) with 
variation in 2’FL concentration (Fig. 1A, B). The majority of women with 
the GG genotype at these loci produced milk with little to no detectable 
2’FL. These two SNPs are in complete linkage and explained 55% of the 
variation observed in 2’FL concentration of milk. Additionally, rs492602 
(which is also in complete linkage with rs679574 and rs516316) and 
rs601338 (which is in very high linkage, D′ = 0.99, with rs679574, 
rs516316, and rs492602) were strongly associated (P < 3.91 × 10− 69 
and P < 4.73 × 10− 69, respectively) with 2’FL (Fig. 1C). Overall, there 
were 24 additional SNPs in this region of chromosome 19 associated 
with 2’FL variation (Fig. 1B). Many of the same SNPs in the region of the 
FUT2 gene also exhibited a strong association with concentrations of 
DFLac and LNFP I; rs601338 exhibited the strongest association (P <
8.13 × 10− 50) with DFLac, whereas rs492602 was most associated (P <
4.31 × 10− 41) with LNFP I. Within the FUT2 gene, several SNPs, 
including rs516246 and rs485186, were also found to be associated with 
concentrations of LNFP II, LNT, and FDSLNH (Fig. 1D). It is noteworthy, 
however, that the above-mentioned SNPs exhibited an inverse rela-
tionship with the concentrations of these HMO, in comparison to that of 
these SNPs to 2’FL, DFLac, and LNFP I (Table 2). 
Associations observed with other HMO include three SNPs associated 
with varying concentrations of DFLNT: rs708686 which lies just up-
stream of FUT6, and rs778986 and rs2561796 which are both located in 
the FUT3 region of chromosome 19, with rs778986 coding a missense 
variant and rs2561796 residing in an intronic region of FUT3. Addi-
tionally, other associations included rs75248127 on chromosome 10 and 
rs185875168 in the intron of RAB31L1 on chromosome 11 that were 
associated with FLNH and LNH, respectively (Supplementary Table S1). 
3.2. Multi-locus GWAS 
Although most of the HMO were associated with only one region of 
the genome, a few exhibited associations with more than one location; 
therefore, multi-locus mixed model analyses were conducted for FLNH, 
LNFP II, LNFP III and LNH. Using the extended Bayesian information 
criterion (EBIC) to determine the optimal model for each HMO, two 
SNPs (one on chromosome 5 and the other on chromosome 10) were 
associated with FLNH (P < 3.62 × 10− 9 and P < 2.49 × 10− 11, respec-
tively); two SNPs on chromosome 19 (rs708686 located between FUT6 
and FUT3 and rs516246 located in FUT2) were associated with LNFP II 
(P < 5.04 × 10− 15 and P < 2.97 × 10− 25, respectively); two SNPs 
(rs185875168 on chromosome 11 and rs778986 on chromosome 19) 
were associated with LNH (P < 4.59 × 10− 11 and P < 1.52 × 10− 10, 
respectively); and two SNPs (rs35231001 on chromosome 4 and 
rs10504422 on chromosome 8) were associated with LNFP III (P < 2.01 
× 10− 12 and P < 5.52 × 10− 10, respectively) (Supplementary Fig. S2). 
3.3. Genome-wide association analyses by secretor status 
Given that the majority of HMO variation is explained by null mu-
tations found in FUT2 and to better understand how variation in con-
centrations of HMO may be regulated differently in secretors and non- 
secretors, we performed separate analyses with secretor women (n =
Table 1 
Most significant single nucleotide polymorphisms associated with variation in oligosaccharide concentrations of milk produced by 11 cohorts of women from 8 
countries.  
HMO Significant SNPs (#) Most significant SNP(s) Chra Position Alternate allele Reference alleleb Assay allelesc Proportion of variance explained P value 
2’FLe 27 rs679574 19 48,702,85 G C [G/C] 0.55 4.50 × 10− 70 
rs516316 19 1 48,702,888 C G [G/C]d 
DFLace 22 rs601338 19 48,703,417 A G [A/G] 0.43 8.13 × 10− 50 
LNFP Ie 24 rs492602 19 48,703,160 G A [C/T]d 0.36 4.31 × 10− 41 
LNFP IIe 26 rs516246 19 48,702,915 T C [A/G]d 0.22 4.02 × 10− 23 
LNFP IIIe 14 rs35231001 4 22,968,709 G A [G/A] 0.14 1.56 × 10− 14 
DFLNTe 3 rs708686 19 5,840,608 T C [T/C] 0.13 6.07 × 10− 14 
FDSLNHe 13 rs516246 19 48,702,915 T C [A/G]d 0.13 7.14 × 10− 14 
LNTe 13 rs485186 19 48,703,94 G A [C/T]d 0.11 3.73 × 10− 11 
rs603985 19 9 48,704,000 C T [C/T] 
LSTbe 6 rs2251034 19 48,704,535 A G [A/G] 0.09 1.06 × 10− 9 
FLNHe 5 rs75248127 10 36,616,538 G A [G/A] 0.09 1.37 × 10− 9 
LNHe 3 rs185875168 11 61,898,945 A G [A/G] 0.09 1.70 × 10− 9  
a Chromosome. 
b Reference allele was designated as the allele found in the top strand of the displayed sequence in dbSNP generated from using GRCh38.p12. 
c Assay alleles are listed with the alternate allele or the allele complementary to the alternate allele listed first and the reference allele or allele complementary to 
reference listed second. 
d Opposite strand used in array design. 
e 2’FL - 2′-fucosyllactose; DFLac - difucosyllactose; LNFP - lacto-N-fucopentaose; DFLNT - difucosyllacto-N-tetrose; FDSLNH - fucodisialyllacto-N-hexaose; LNT - 
lacto-N-tetrose; LSTb - sialyl-lacto-N-tetraose b; FLNH - fucosyllacto-N-hexaose; LNH - lacto-N-hexaose. 
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305) and non-secretor women (n = 90). When data from secretor only 
women were evaluated using EMMAX, concentrations of LNFP II and 
DFLNT were still associated with rs708686 on chromosome 19 (Sup-
plementary Fig. S3; Table S2). Additionally, LNFP I was significantly (P 
< 7.48 × 10− 10) associated with rs708686. DFLNT was also once again 
associated with rs2561796 and rs778986 in the FUT3 region of chro-
mosome 19. One SNP on chromosome 1 (rs77634072) was associated 
with 3FL concentration (P < 5.76 × 10− 10). These analyses were 
generally consistent with the analyses done with all of the women 
included. When only data from non-secretor women were evaluated, 
Fig. 1. (A) Manhattan plot of GWAS analyses with 2’FL. The –log10 P-values for each SNP from a genome-wide scan are plotted against their position on each of the 
23 chromosomes. The red horizontal line indicates the genome-wide significance threshold (P < 1 × 10− 8). (B) Zoomed in view of Manhattan plot around FUT2 gene 
region. (C) Boxplots of the 4 most significant loci for 2’FL where dots represent individual women’s concentrations of HMO by genotype. (D) Boxplots of most 
significant SNP for LNFP II and FDSLNH (rs516246) and most significant SNP for LNT (rs485186) and their associations with concentrations of LNFP II, LNT, and 
FDSLNH, and the inverse relationships with concentrations of 2FL, DFLac, and LNFP I. Dots represent individual women’s samples. (For interpretation of the ref-
erences to colour in this figure legend, the reader is referred to the web version of this article.) 
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one SNP in lncRNA on chromosome 5 (rs17312027) was associated with 
variation in DFLNH concentration; and rs79318201 on chromosome 10 
was associated with LSTc (Supplementary Fig. S3; Table S3). 
3.4. Genetic relatedness of study participants 
To examine the distribution in the genetic relatedness of the 395 
women, we performed a PCA (Fig. 2). Visual inspection of the PCA plot 
suggested that samples clustered into 4 main groups. Samples from The 
Gambia, Kenya, and Ghana cohorts clustered together (PC group 4), 
while samples from the two Ethiopian cohorts formed another cluster 
(PC group 3). Samples from Spain and Sweden clustered with most of the 
samples from USW and a few from USC (PC group 2), and most of the 
samples from USC and Peru formed a broader cluster (PC group 1) 
(Supplementary Table S4). 
3.5. Haplotype block analyses of genetic variation in FUT2 and FUT3 
genes 
Haplotype block analysis revealed two blocks across the FUT2 gene. 
Haplotype blocks are defined as arrays of two or more SNPs with high 
linkage disequilibrium (LD). Haplotype block 1 consisted of six SNPs 
that were all in very high LD among each other, (e.g. R2 ranged from 
0.98–1.0 among rs679574, rs516316, rs516246, rs492602, rs681343, 
and rs601338 (Supplementary Table S5). Haplotype block 2 consisted of 
seven SNPs (rs602662, rs485186, rs603985, rs2251034, rs504963, 
rs632111 and rs503279) that although not as high as that observed for 
Block 1, still exhibited strong LD (e.g. R2 ranged from 0.76–1.0). The 
frequency of block 1 and 2 diplotypes across the PC groups are displayed 
in Fig. 3A. Most of the women in PC Group 1 (86%; 48/56) were ho-
mozygous for the Block 1 diplotype CCGTCG|CCGTCG; whereas each of 
the other 3 PC groups displayed a more varied frequency with presence 
of up to three or four different diplotypes (Fig. 3A). Block 1 and block 2 
diplotypes also exhibited linkage disequilibrium. For example, those 
with the CCGTCG|CCGTCG diplotype in block 1 more often (85%) had 
the GTTGCAA|GTTGCAA diplotype in block 2; conversely, those with 
the GGACTA|GGACTA diplotype were more often (82%) homozygous 
for the block 2 ACCATGG|ACCATGG diplotype. Interestingly, no 
haplotype blocks were detected in the FUT3 region. 
3.6. Haplotypes by PC group 
After phasing the 24 markers found within FUT2, 49 unique haplo-
types were inferred (Supplementary Table S5 and S6). To visualize the 
relationships among the haplotypes and better understand the distri-
bution of haplotypes by individuals with similar genetic backgrounds, a 
median joining network of the haplotypes was constructed for FUT2 
(Fig. 3B). The haplotype network is divided into two main groups, Se 
and se, with the null mutation variant rs601338 described by Kelly et al. 
1995 [11] defining the two groups. Within the Se group there were two 
predominant haplotypes (Se15 and Se21) with a third less common 
haplotype (Se32) in PC group 1. In the se group, one major haplotype 
(se12) was observed, along with se3 being another haplotype that was 
found predominantly in individuals in PC group 4. These two haplotypes 
only differed by one marker (rs590017) which is found in the intron of 
FUT2. Less common haplotypes were often found in PC Groups 3 and 4. 
To investigate FUT3, we examined how the haplotype structure for 
FUT3 might vary across the four PC groups. Fourteen unique FUT3 
haplotypes were inferred, with one (Hap6) containing the previously 
reported null mutation at rs59796499 (Supplementary Table S7). 
However, none of the individuals in this study were homozygous for this 
variant. Five haplotypes were commonly observed for FUT3 in PC 
groups 2, 3, and 4; whereas, in PC groups 3 and 4 some additional less 
common haplotypes were observed (Supplementary Fig. S4). 
3.7. Population genetic statistics 
To test if FUT2 and FUT3 are under selective pressure, we examined 
various neutrality indices. Utilizing the markers for FUT2, Tajima’s D for 
the entire study population was found to be significant and positive 
(3.30, P = 0.003) suggesting FUT2 is under balancing selection. Inter-
estingly, when evaluating by PC groups, PC group 2, 3, and 4 were each 
positive (2.88, 2.38, 3.0; P < 0.025). Conversely, although not signifi-
cant, a negative Tajima’s D was observed for PC group 1 (− 0.67; P =
0.727). Additionally, nucleotide diversity (π) of FUT2 was examined and 
found to be similar among PC groups 2, 3, and 4 (π = 0.31, 0.32, 0.34, 
respectively), whereas, PC group 1 had a value of 0.12 for π. When 
evaluating FUT3, Tajima’s D was not significant (0.34; P = 0.693) for the 
entire study population, but when examined by PC group, PC group 2 
Table 2 
SNP that display significant associations with HMO but have different directions of the beta coefficient associated with the model fit depending on the HMO it is 
associated with.  
rsID Chra Position Gene: Consequence HMO Negative Betab HMO Positive Betab 
rs679574 19 48,702,851 FUT2: intron variant; LOC105447645: non-coding transcript variant 2’FL, DFLac, LNFP I LNFP II, LNT, FDSLNH 
rs516316 19 48,702,888 FUT2: intron variant; LOC105447645: non-coding transcript variant 2’FL, DFLac, LNFP I LNFP II, LNT, FDSLNH 
rs516246 19 48,703,160 FUT2: intron variant; LOC105447645: non-coding transcript variant 2’FL, DFLac, LNFP I LNFP II, LNT, FDSLNH 
rs492602 19 48,703,160 FUT2: synonymous variant; LOC105447645: non-coding transcript variant 2’FL, DFLac, LNFP I LNFP II, LNT, FDSLNH 
rs681343 19 48,703,205 FUT2: stop gained; LOC105447645: non-coding transcript variant 2’FL, DFLac, LNFP I LNFP II, LNT, FDSLNH 
rs601338 19 48,703,417 FUT2: stop gained; LOC105447645: non-coding transcript variant 2’FL, DFLac, LNFP I LNFP II, LNT, FDSLNH 
rs602662 19 48,703,728 FUT2: missense variant; LOC105447645: non-coding transcript variant 2’FL, DFLac, LNFP I LNFP II, LNT, FDSLNH 
rs485186 19 48,703,949 FUT2: synonymous variant; LOC105447645: 2 KB upstream variant 2’FL, DFLac, LNFP I LNFP II, LNT, FDSLNH, LSTb 
rs603985 19 48,704,000 FUT2: 3’ UTR variant; LOC105447645: 2 KB upstream variant 2’FL, DFLac, LNFP I LNFP II, LNT, FDSLNH, LSTb 
rs2251034 19 48,704,535 FUT2: 3’ UTR variant; LOC105447645: 2 KB upstream variant 2’FL, DFLac, LNFP I LNFP II, LNT, FDSLNH, LSTb 
rs504963 19 48,705,608 FUT2: 3’ UTR variant; LOC105447645: 2 KB upstream variant 2’FL, DFLac, LNFP I LNFP II, LNT, FDSLNH 
rs632111 19 48,705,721 FUT2: 3’ UTR variant; LOC105447645: 2 KB upstream variant 2’FL, DFLac, LNFP I LNFP II, LNT, FDSLNH 
rs503279 19 48,705,753 FUT2: 3’ UTR variant; LOC105447645: 2 KB upstream variant 2’FL, DFLac, LNFP I LNFP II, FDSLNH 
rs281379 19 48,711,017  2’FL, DFLac, LNFP I LNFP II 
rs281380 19 48,711,213  LNFP II 2’FL, DFLac, LNFP I 
rs281393 19 48,721,227 RASIP1: missense variant; MAMSTR: 2 KB upstream variant LNFP II 2’FL, DFLac, LNFP I 
rs2287921 19 48,725,015 RASIP1: intron variant 2’FL, DFLac, LNFP I LNFP II 
rs838147 19 48,743,609 IZUMO1: intron variant 2’FL, DFLac, LNFP I LNFP II 
rs8108468 19 48,744,529 IZUMO1: synonymous variant LNFP II 2’FL, LNFP I 
rs8111399 19 48,744,706 IZUMO1: intron variant LNFP II 2’FL, LNFP I 
rs838145 19 48,745,473 IZUMO1: intron variant 2’FL, DFLac, LNFP I LNFP II  
a Chromosome. 
b 2’FL - 2′-fucosyllactose; DFLac - difucosyllactose; LNFP - lacto-N-fucopentaose; FDSLNH - fucodisialyllacto-N-hexaose; LNT - lacto-N-tetrose; LSTb - sialyl-lacto-N- 
tetraose b. 
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had a significant positive Tajima’s D (2.30; P = 0.033) and all others 
were not significant. Values of π for PC groups 1, 2, 3, and 4 were similar 
for FUT3 (π = 0.13, 0.16, 0.17, 0.16, respectively). 
4. Discussion 
This study represents the first GWAS of variation in HMO, collected 
from approximately 400 women residing in 8 different countries. We 
identified genetic loci that are significantly associated with 11 different 
HMO, the most significant being with 2’FL (P < 4.50 × 10− 70). Poly-
morphisms identified in the FUT2 and FUT3 genes were associated with 
variation in the concentration of eight HMO. These associations are 
consistent with findings from previous research that have demonstrated 
a strong correlation between HMO profile and activity of fucosyl-
transferases that are encoded by the FUT2 and FUT3 genes [13,26–28]. 
The multiple associations among these SNPs with some of the HMO 
such as 2’FL were due to the high LD found in this region. For example, 
the genotypes in rs679574 and rs516316 are in complete LD and 
consequently both of these SNPs are in very high linkage disequilibrium 
(R2 = 0.99) with rs601338, a previously described nonsense mutation in 
the FUT2 gene [11]. Interestingly, several SNPs located within FUT2 
were significantly associated with a number of different oligosaccha-
rides including 2’FL, DFLac, LNFP I, LNFP II, LNT, FDSLNH, and LSTb; 
however, the direction of the beta coefficients for the relationships with 
2’FL, DFlac, and LNFP I was opposite from the direction of those with 
LNFP II, LNT, FDSLNH, and LSTb. This is evidence that the negative 
correlation, previously documented by McGuire et al. (2017) and Azad 
et al. (2018), can be attributed to specific genetic variants. It also pro-
vides additional evidence that women without a missense SNP have a 
functioning enzyme encoded from FUT2, and thus have an HMO profile 
rich in 2’FL, DFLac, LNFP I, whereas women with genotypes that include 
the missense mutation at rs60188 have a nonfunctioning enzyme 
resulting in a different HMO profile with higher concentrations of HMO 
such as LNFP II and LNT. 
Our data are consistent with results from a previous study that uti-
lized restriction fragment length polymorphism PCR and enzyme 
digestion to distinguish the genotype at rs601338 [29]. In this study, the 
authors found the genotypes from this SNP were correlated with the 
levels of HMO. The authors observed that all mothers who were deter-
mined to be homozygous non-secretors at this allele were also non- 
secretors in phenotype, i.e. produced milk with little to no 2’FL. How-
ever, of the secretors, two individuals produced milk with little 2’FL 
early in lactation (e.g., day 6); but later in lactation (day 120), they 
produced levels indicative of a secretor. In our study, we also observed 
that the majority of women displayed consistency between the secretor/ 
non-secretor genotypes and expected profiles for HMO such as 2’FL. 
However, there were few instances where the relationships between 
SNPs and HMO concentrations did not hold true. Notably, there were 6 
individuals (5 from GN and 1 from GBR) whose genotypes at the stop- 
gain marker rs601338 in FUT2 were predictive of a functional enzyme 
but had <200 nmol/mL 2’FL in their milk. It is possible that there are 
other mutations or indels present but which are not represented on the 
MEGA and/or other environmental factors which resulted in a non- 
secretor phenotype. Furthermore, two individuals exhibited a dip-
lotype consistent with a non-secretor diplotype. However, they differed 
at one specific site, the functional allele at rs601338; milk produced by 
these individuals had >200 nmol/mL 2’FL. 
This study also elucidated genomic regions other than FUT2 associ-
ated with HMO composition. Two SNPs located in FUT3 (rs778986 and 
rs2561796) and one SNP located near FUT6 (rs708686) were associated 
with concentrations of DFLNT. Interestingly, rs708686, along with other 
SNPs in FUT6, a gene that encodes a fucosyltransferase enzyme that 
catalyzes the addition of a fucose exclusively onto type 2 precursor 
chains [30], and SNPs in FUT2 (including rs602662 and rs601338) are 
also associated with plasma vitamin B12 status [31]. Using a meta- 
analysis approach, Nongmaithem and coworkers (2017) observed an 
association (P = 5.7 × 10− 15) between rs708686 and plasma B12 con-
centrations in 4419 Indo-European and Dravidian individuals from six 
cohorts. They noted that the relationships persisted across a wide range 
of factors including age, gender, and ethnicities, suggesting a strong 
genetic contribution to variation in plasma vitamin B12 concentrations. 
The authors also investigated potential differences in the binding of 
transcription factors across variants in FUT6. Although they reported 
promotor and/or enhancer activity for some of the SNP in FUT6, they 
did not observe any allele-specific differential binding of transcription 
factors with variation at rs708686. The biological implication, however, 
for alterations in both plasma vitamin B12 and HMO concentrations 
being induced by genetic variation in FUT6 warrants further research. 
The fucosyltransferase gene family has long been studied both from a 
biological and evolutionary standpoint as these genes play an integral 
role in determining cell surface markers and blood group antigens 
[32,33]. The evolutionary history of these genes, in particular for FUT2 
and FUT3, have been described in several populations, many of which 
overlap with our study populations [34–37]. For example, the primary 
non-functional allele in FUT2, rs601338, observed in our cohorts has 
also been reported to be the primary nonfunctional allele in Europeans 
and Africans [33]. Similar to results reported by Soejima and coworkers 
(2007) who reported evidence of balancing selection for FUT2 in a 
Ghanaian cohort, our findings for Tajima’s D also indicate that the ge-
netic diversity in FUT2 in our study populations is not only the result of 
Fig. 2. Principal component analysis (PCA) plot displaying the genetic relatedness of the women participating in the INSPIRE study. Dots represent individual 
samples and are colored by site of sample collection. Colored ellipses display PC groupings. EV = eigenvalue. 
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Fig. 3. (A) Distribution of Block 1 and Block 2 FUT2 diplotypes by PC Group. Block 1 consists of 6 markers, rs679574, rs516316, rs516246, rs492602, rs681343, and 
rs601338, with the bold letter in the Block 1 diplotype representing the rs601338 marker. Block 2 consists of 7 markers, rs602662, rs485186, rs603985, rs2251034, 
rs504963, rs632111, rs503279 (B) Median joining network of FUT2 haplotypes found in the 4 PC groups. Each circle represents a specific haplotype and the size of 
the circle is proportional to the frequency of that haplotype. The colored areas within each circle are proportional to the frequency of the haplotype for the PC group 
(PC group 1 - red, PC group 2 - green, PC group 3 - purple, and PC group 4 - yellow). (For interpretation of the references to colour in this figure legend, the reader is 
referred to the web version of this article.) 
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mutation and genetic drift but also of balancing selection. 
Balancing selection is an adaptive force that maintains genetic 
variation in populations. The evidence of balancing selection observed 
for FUT2 in PC groups 2, 3, and 4 suggest that diversity of alleles in FUT2 
may offer some benefit in these populations. Conversely, in the case of 
PC group 1 (primarily secretors [49/50]) where no evidence of 
balancing selection was found, there may be benefit to secretor status or 
alternatively, allelic variation has been reduced by genetic drift which 
removes polymorphisms from populations. It is noteworthy, however, 
that as these fucosyltransferase genes are also linked to ABO histo-blood 
groupings, disentangling the contribution of HMO to the molecular 
evolution of these pleiotropic genes is difficult. For example, presence or 
absence of glycoproteins on the surface of epithelial cells and erythro-
cytes and/or presence or absence of HMO may increase or decrease the 
risk of disease or infection by various pathogens [3,38]. 
Work from the 1000 Genomes Project Consortium indicates that 
individuals with African ancestry have the greatest number of variant 
sites, which is also observed in our study populations [39]. Additionally, 
we observed 31 unique haplotypes and 24 segregating sites for FUT2 in 
PC group 4 which was comprised mainly of individuals living in Africa. 
In alignment with what others have reported, we also observed PC group 
4 as having the highest Tajima’s D value across the PC groups. However, 
in contrast to the balancing selection observed for FUT2, we did not 
observe evidence of selective pressure for FUT3. This could be due to the 
low number of SNPs in FUT3 which had passed the filtering step in our 
analyses and resulting in few SNP being evaluated in the neutrality tests. 
Although our study was somewhat limited by having a relatively 
small number of individuals in each cohort, these results provide strong 
evidence for the impact of mutations in FUT2 and FUT3 on HMO 
composition. Our data also support previous results that have shown the 
null mutation at rs601338 in FUT2 has a high prevalence among Cau-
casians as well as African populations. When this nonsense mutation is 
homozygous in individuals, we observed very little 2’FL and other HMO 
that stem from this branch-chain base. Surprisingly, we observed little 
evidence of genes other than FUT2 and FUT3 being associated with HMO 
composition. We also attempted to elucidate additional variants that 
would help explain the variation in HMO concentrations by examining 
the HMO profiles in milk from secretor (all HMO) and non-secretor 
women (excluding 2’FL, DFLac, LNFP I) separately. Because the HMO 
profiles are distinct between these two groups, i.e. secretor and non- 
secretor women, we could then potentially identify genetic associa-
tions that could explain the variation of specific HMO that might be 
more prevalent in one group or the other. Once again, we found 
rs708686 to be associated with DFLNT and LNFP II in secretor women. 
We did not however, find these association in non-secretor women. 
Instead, we found rs17312027 and rs79318201 were associated with 
DFLNH and and LSTc, respectively. It is possible that a large number of 
individuals in these populations would be necessary to uncover the 
potential small gene effect on HMO diversity. More research is needed to 
identify additional mechanisms and factors that result in such wide 
ranges of HMO concentrations. 
In conclusion, our study is the first report to use a GWAS to inves-
tigate the contribution of genetic variation to HMO composition. Un-
derstanding the influence of genetic polymorphisms on HMO synthesis 
is important not only as evidence continues to mount that various HMO 
play a role in the health of the infant, but also in that these same genes 
may impact the health of the infant through other mechanisms, like 
vitamin B12 status [40] and risk of virus infection and respiratory and 
gastrointestinal illnesses [as reviewed [14,41]. 
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